Báo cáo y học: "Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells. | Han et al. Journal of Immune Based Therapies and Vaccines 2010 8 8 http content 8 1 8 JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES ORIGINAL RESEARCH Open Access Ex vivo development expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells 1 2 11 13 4 Shuhong Han Yichen Wang Bei Wang Ekta Patel Starlyn Okada Li-Jun Yang Jan S Moreb Lung-Ji Chang1 Abstract Dendritic cells DCs play a key role in innate and adaptive immunity but the access to sufficient amount of DCs for basic and translational research has been limited. We established a novel ex vivo system to develop and expand DCs from hematopoietic stem progenitor cells HPCs . Both human and mouse HPCs were expanded first in feeder culture supplemented with c-Kit ligand KL stem cell factor steel factor or CD117 ligand Flt3 ligand fms-like tyrosine kinase 3 Flt3L FL thrombopoietin TPO IL-3 IL-6 and basic fibroblast growth factor bFGF and then in a second feeder culture ectopically expressing all above growth factors plus GM-CSF and IL-15. In the dual culture system CD34 HPCs differentiated toward DC progenitors DCPs which expanded more than five orders of magnitude. The DCPs showed myeloid DC surface phenotype with up-regulation of transcription factors and Id2 and DC-related factors homeostatic chemokine ligand 17 CCL17 and beta-chemokine receptor 6 CCR6 . Multiplex ELISA array and cDNA microarray analyses revealed that the DCPs shared some features of IL-4 and IL-15 DCs but displayed a pronounced proinflammatory phenotype. DCP-derived DCs showed antigen-uptake and immune activation functions analogous to that of the peripheral blood-derived DCs. Furthermore bone marrow HPC-derived DCP vaccines of tumor-bearing mice suppressed tumor growth in vivo. This novel approach of generating DCP-DCs which are different from known IL-4 and IL-15 DCs overcomes both quantitative and qualitative limitations in obtaining functional autologous DCs from a small .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
24    17    1    24-11-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.